A Study to Evaluate the Long-term Safety of Inclacumab Administered to Participants With Sickle Cell Disease
An Open-Label Extension Study to Evaluate the Long-Term Safety of Inclacumab Administered to Participants With Sickle Cell Disease Who Have Participated in an Inclacumab Clinical Trial
Category & Conditions: Rare Diseases
Medicine: INCLACUMAB(PF-07940370)
ClinicalTrials.gov Identifier (NCT): NCT05348915
Protocol ID: C5361003 (or GBT2104-133)
Language: English
Open Plain Language Summary Result:
Click here